Showing results (321-330 of 332) with videos related to

Sort By:
Pageof 34
Cancer Discovery|September 26, 2013
Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLCAnnette O Walter, Robert Tjin Tham Sjin, Henry J Haringsma, et al.
Elife|January 9, 2025
A high-throughput platform for single-molecule tracking identifies drug interaction and cellular mechanismsDavid Trombley McSwiggen, Helen Liu, Ruensern Tan, et al.
Molecular Cancer|February 3, 2025
Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteinsMaria Angelica Freitas-Cortez, Fatemeh Masrorpour, Hong Jiang, et al.
Nature Communications|March 5, 2025
Structure-function relationship of ASH1L and histone H3K36 and H3K4 methylationKendra R Vann, Rajal Sharma, Chih-Chao Hsu, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|October 24, 2023
Rationale for the Development of a Novel Clinical Grading Scale for Postoperative Facial Nerve Function: Results of a Multidisciplinary International Working GroupMatthew L Carlson, Christine M Lohse, Siviero Agazzi, et al.
Nature Metabolism|October 27, 2020
Mitochondrial pyruvate carriers are required for myocardial stress adaptationYuan Zhang, Paul V Taufalele, Jesse D Cochran, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistanceKsenija Nesic, John J Krais, Cassandra J Vandenberg, et al.
Molecular Cancer|August 5, 2024
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistanceKsenija Nesic, John J Krais, Yifan Wang, et al.
Science (New York, N.Y.)|December 15, 2018
Genome-wide de novo risk score implicates promoter variation in autism spectrum disorderJoon-Yong An, Kevin Lin, Lingxue Zhu, et al.
Pageof 34